The Cognomics Project

  • Increase font size
  • Default font size
  • Decrease font size
Home News and Results Newsflash MiND European Training Network is hiring

MiND European Training Network is hiring

MiND logo

EU Marie Sklodowska-Curie project ‘MiND’: put your mind to work on ADHD and autism.

Attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are common neurodevelopmental disorders affecting both children and adults. Despite their societal importance, progress in understanding disease biology has been slow and treatment options are limited.

The pan-European training network MiND (www.MiND-project.eu), a strategic collaboration of world-leading academic groups, research-intensive commercial enterprises and patient organizations, aims to substantially increase our knowledge about the etiology of ADHD and ASD through interdisciplinary research. We combine advanced (epi-)genetics, epidemiological, and neuroscientific approaches with bioinformatics and will develop novel cell and animal models of increasing complexity to understand the biology of cognition. Our mechanistic work is embedded in a framework exploring disease definitions for ADHD and ASD across the lifespan and will contribute substantially to improved disease management. Within MiND, we will identify new compounds for pharmacological treatment, establish novel animal models to test these, probe the microbiome for dietary interventions reducing symptoms and evaluate mindfulness training as a non-pharmacological treatment option.

The MiND programme is now looking for 15 highly motivated Early Stage Researchers (ESRs), researchers with a BSc or MSc degree within the first four years (full-time equivalent) of their research career. We offer a comprehensive, interactive and international PhD training programme covering innovative and state-of-the-art approaches to current ADHD and ASD research. Training will be staged according to the 5 ‘i’ principle: innovation-oriented, intersectoral, international, interdisciplinary and individualized. The programme will combine research-specific skills, complementary skills and soft skills, and will involve both the academic and private sectors aimed to prepare all researchers optimally for their future careers.

Short descriptions of the individual projects and the details on how to apply for them are given at www.MiND-project.eu. Applications should consist of an up-to-date CV as well as a cover letter including the applicants’  motives to apply and the contact details of two referees. Only complete applications will be considered. According to the requirements of the prestigious Marie Sklodowska Curie Training Programme, applicants may not have resided or carried out their main activity (work, study, etc.) for more than 12 months in the last 3 years in the country of the host institute of a position of interest. Applicants should have an excellent proficiency in written and spoken English. A mobility allowance and a family allowance (where applicable) are part of the employment package. All applications should be sent to the respective recruitment officer before Monday the 2nd of February 2015. Acquisition following this vacancy is not appreciated.


Position

Subject title

ESR1

Adverse and functional outcomes of ADHD with and without ASD.

ESR2/3

Overlapping and differential clinical and cognitive endophenotypes of ASD and ADHD in children and adolescents and adults.

ESR4

Overlap and specificity in genetic predisposition to neurodevelopmental disorders - common genetic variants.

ESR5

Novel genetic models for ADHD and ASD.

ESR6

Novel NGS approaches to validate candidate genes in ASD and ADHD.

ESR7

Effects of the microbiome in human behaviour.

ESR8

Epigenetic gene regulation in mouse and human.

ESR9

Development of cellular model systems.

ESR10

Drosophila models for neuropsychiatric disorders.

ESR11

Novel zebrafish models for neuropsychiatric disorders.

ESR12

Longitudinal modelling of cognition, human brain connectivity and genetics in ASD and ADHD.

ESR13

Prediction of prognosis and disease outcome.

ESR14

Drug Discovery: pharmacological modification of target proteins.

ESR15

Mindfulness research in ADHD.

Last Updated on Wednesday, 14 January 2015 12:42